Common side effects include nausea, diarrhea and constipation, which typically subside as the body adjusts to the medication. There are strategies to manage and minimize side effects
[DOI] [PubMed] [Google Scholar] 3.Burch R.C., Buse D.C., Lipton R.B
[56] Additionally, by blockading FOXO transcription factors and NF-B, the drug modulates SASP and upregulates anti-apoptotic proteins (such as Bcl-2), potentially delaying tissue degeneration and offering anti-aging benefits
When an Integrative Approach Makes Sense There are situations where GLP-1 medications are medically necessary, particularly in advanced type 2 diabetes or severe metabolic disease
We have a full summary of all the major pre-clinical studies and trials below, but as Reta is in Phase III, it's clear that: It showed significant benefit and low safety risk during pre-clinical trials to justify clinical trials
Neuropharmacology 157:107668